301584SZSE

Report on the 2025 Annual Continuous Supervision On-site Inspection of Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. by CITIC Securities Co., Ltd.

✨ AI Summary

This report outlines the findings from the on-site inspection conducted by CITIC Securities for Shanghai Jianfa Zhixin Medical Technology Group. The inspection covered corporate governance, internal controls, information disclosure, and the use of raised funds. No significant issues were identified during the inspection, indicating compliance with relevant regulations and effective management practices.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Report on the 2025 Annual Continuous Supervision On-site Inspection of Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. by CITIC Securities Co., Ltd.

Sponsor Name: CITIC Securities Co., Ltd. (hereinafter referred to as "CITIC Securities" or "Sponsor")
Abbreviated Name of the Sponsored Company: Jianfa Zhixin
Sponsor Representative Name: Zhang Lei
Contact Number: 18616500829
Sponsor Representative Name: Shen Ziquan
Contact Number: 15010705886
On-site Inspection Personnel Names: Zhang Lei, Shen Ziquan
Inspection Period: September 25, 2025 - December 31, 2025
Inspection Dates: April 15, 2026, April 24, 2026, May 28, 2026 (if inspection times differ, please list separately)

I. On-site Inspection Matters

On-site Inspection Opinions

(1) Corporate Governance

ItemYesNoNot Applicable
1. Are the company's articles of association and governance systems complete and compliant?
2. Are the articles of association and meeting rules effectively executed?
3. Are the meeting records complete, including time, place, attendees, and content, and are the materials preserved intact?
4. Are the meeting resolutions signed by relevant attendees?
5. Do the directors, supervisors, and senior management fulfill their duties according to laws, regulations, and relevant rules?
6. If there are significant changes in directors, supervisors, or senior management, have corresponding procedures and disclosure obligations been fulfilled?
7. If there are changes in the controlling shareholder or actual controller, have corresponding procedures and disclosure obligations been fulfilled?
8. Are the company's personnel, assets, finances, institutions, and business independent?
9. Is there no competition between the company and its controlling shareholder or actual controller?

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.